Tests:Carcinoembryonic Antigen: Difference between revisions
- Department
- Biochemistry
Tests:Carcinoembryonic Antigen
Created page with "{{DISPLAYTITLE: Carcinoembryonic Antigen}} Full Test List Biochemistry Tests {| class="wikitable" ! colspan="2" | ===''Overview''=== |- |Department |Biochemistry |- |Test Code |TCEA |- |Synonyms |CEA |- |Turnaround Time |2 hours – 3 days |- |Stability – Add test |24 hours |- ! colspan="2" | ===''Specimen Requirements''=== |- |Specimen Type |6 mL <span style="background:#e30022"> red top </span> or <span style="background: #fbec5d"> yellow top</span>..." |
No edit summary |
||
| Line 38: | Line 38: | ||
|- | |- | ||
|Pediatric Requirements | |Pediatric Requirements | ||
|Minimum 0.5 mL blood in 6 mL | |Minimum 0.5 mL blood in 6 mL <span style="background:#e30022"> red top </span> | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
Revision as of 15:35, 20 January 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | TCEA |
| Synonyms | CEA |
| Turnaround Time | 2 hours – 3 days |
| Stability – Add test | 24 hours |
Specimen Requirements | |
| Specimen Type | 6 mL red top or yellow top |
| Specimen Transportation | |
| Preferred | |
| Acceptable | |
| Pediatric Requirements | Minimum 0.5 mL blood in 6 mL red top |
Aliquot Requirements | |
| Sample Type | |
| Minimum Volume | 100 uL |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | 0.0 - 5.0 ug/L |
| Test Method | Abbott Alinity Ci using Abbott reagents. |
| Advanced Notice | Not Required |
| Patient Preparation | Not Required |
Comments | |
| CEA is a marker for colorectal, gastrointestinal, lung and breast carcinomas.
CEA levels are not an absolute test for evidence of malignancy and must be used in conjunction with the clinical evaluation of the patient and other diagnostic evidence. Healthy non-smokers have CEA levels less than 3.0 µg/mL, while 6% of otherwise healthy smokers have CEA levels up to 5.0 µg/mL. CEA is not suitable as a screening test for the primary diagnosis of tumours. For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |